[1]
V. C. de . Souza, R. de B. . Silva, and C. . Antunis, “INTERFERON I AS A THERAPEUTIC TARGET IN THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS: USE OF MONOCLONAL ANTIBODIES ANIFROLUMAB, RONTALIZUMAB AND SIFALIMUMAB”, REASE, vol. 9, no. 1, pp. 717–731, Jan. 2023.